POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK)
| Autor: | Reifsnider, O, Tafazzoli, A, Bellanca, L, Litkiewicz, M, Stargardter, M, Linden, S |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S58-S58 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect